Mural Oncology

Yahoo Finance • yesterday

$HAREHOLDER ALERT: The M&A Class Action Firm Reminds Shareholders of Upcoming Merger Deadlines – AMWD, PHLT, ARIS, and MURA

NEW YORK, Sept. 28, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in t... Full story

Yahoo Finance • 3 days ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PHLT, ARIS, MURA on Behalf of Shareholders

NEW YORK, Sept. 27, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to sharehold... Full story

Yahoo Finance • 3 days ago

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate Merger – AMWD, PHLT, ARIS, and MURA

NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in t... Full story

Yahoo Finance • 6 days ago

Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting

WALTHAM, Mass. and DUBLIN, Ireland, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc, (Nasdaq: MURA) (“Mural”), a clinical-stage immuno-oncology company, today announces for the purposes of the Irish Takeover Panel Act, 1997, Takeov... Full story

Yahoo Finance • 6 days ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARIS, MTSR, GTLS, MURA on Behalf of Shareholders

NEW YORK, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to sharehold... Full story

Yahoo Finance • 6 days ago

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate Merger – GTLS, PHLT, ARIS, and MURA

NEW YORK, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in t... Full story

Yahoo Finance • 18 days ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NWE, GES, MURA, TZUP on Behalf of Shareholders

NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to sharehold... Full story

Yahoo Finance • 18 days ago

$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger – NWE, GES, MURA, and TZUP

NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in t... Full story

Yahoo Finance • last month

Citadel Group discloses 1.61% stake in Mural Oncology

DUBLIN - Investment firm Citadel Group has disclosed a 1.61% stake in Mural Oncology plc, according to a regulatory filing published Tuesday. The disclosure, made under Irish Takeover Panel rules, shows Citadel holds 280,225 shares repres... Full story

Yahoo Finance • last month

Citadel Group discloses 2.81% stake in Mural Oncology

DUBLIN - Investment firm Citadel Group has disclosed a 2.81% stake in Mural Oncology plc, according to a regulatory filing published Thursday. The disclosure, made under Irish Takeover Panel rules, shows Citadel holds interests in 487,600... Full story

Yahoo Finance • last month

Traders are paying attention to the gapping stocks in Wednesday's session.

The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session. [gap] TODAY'S GAP UP STOCKS TICKER CHANGE COMMENT NBY [https://www.chartmill.com/stock/q... Full story

Yahoo Finance • last month

Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share

WALTHAM, Mass. and DUBLIN and EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company (“Mural”), and XOMA Royalty Corporation (Nasdaq: XOMA), a biotechnology royal... Full story

Yahoo Finance • last month

WALTHAM, DUBLIN, EMERYVILLE - Mural Oncology agrees to acquisition by XOMA Royalty subsidiary

WALTHAM, Mass., DUBLIN, Ireland and EMERYVILLE, Calif. - Mural Oncology plc (NASDAQ:MURA) has entered into a definitive agreement to be acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty Corporation (NASDAQ:XOMA), for bet... Full story

Yahoo Finance • 2 months ago

Citadel Group discloses 1.58% stake in Mural Oncology

DUBLIN - Investment firm Citadel Group has disclosed a 1.58% ownership position in Mural Oncology plc, according to a regulatory filing published Friday. The disclosure, made under Irish Takeover Panel rules, reveals Citadel holds interes... Full story

Yahoo Finance • 2 months ago

Unusual volume stocks in Monday's session

Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume. [unusualvolume] UNUSUAL VOLUME STOCKS TICKER CHANGE COMMENT AUUD [https://www.chartmill.com/stock/quote/AUUD/profile]... Full story

Yahoo Finance • 2 months ago

These stocks are moving in today's pre-market session

As the US market prepares to open on Wednesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses. [premarket] GAINERS TICKER CHANGE COMMENT REPL [htt... Full story

Yahoo Finance • 3 months ago

BlackRock discloses 1.65% stake in Mural Oncology

DUBLIN - Investment management firm BlackRock (NYSE:BLK), Inc. has disclosed a 1.65% stake in Mural Oncology plc, according to a regulatory filing published Friday. The disclosure, made under Rule 8.3 of the Irish Takeover Panel Act, reve... Full story

Yahoo Finance • 4 months ago

Mural Oncology Announces Number of Relevant Securities in Issue

WALTHAM, Mass. and DUBLIN, May 19, 2025 (GLOBE NEWSWIRE) -- In accordance with Rule 2.12 of the Irish Takeover Panel Act 1997, the Irish Takeover Rules 2022 (the “Irish Takeover Rules”), Mural Oncology plc (Nasdaq: MURA), a clinical-stag... Full story

Yahoo Finance • 6 months ago

Mural Oncology Provides Update on Phase 3 ARTISTRY-7 Trial of Nemvaleukin in Combination with KEYTRUDA® (pembrolizumab) in Patients with Platinum-Resistant Ovarian Cancer

Based on overall survival data observed in interim analysis in platinum-resistant ovarian cancer, Mural will not progress trial to final analysis Continued demonstration of favorable tolerability profile generally consistent with previous... Full story

Yahoo Finance • 7 months ago

Mural Oncology Announces Fourth Quarter and Year End 2024 Financial Results and Highlights Upcoming Clinical Milestones

Interim analysis of overall survival in potentially registrational phase 3 ARTISTRY-7 trial in platinum-resistant ovarian cancer expected in late Q1/early Q2 2025 Top-line data readout of potentially registrational phase 2 ARTISTRY-6 (coh... Full story